NEW YORK (TheStreet) -- CHANGE IN RATINGS
Advanced Energy Industries (AEIS) was upgraded to buy at TheStreet Ratings.
Abercrombie & Fitch (ANF) downgraded at Wells Fargo to market perform from outperform. Estimates were also cut, with no signs of a recovery in sight, Wells Fargo said.
Gamestop (GME) was upgraded at Needham to buy from hold. $60 price target. Company is leveraged to new console releases, Needham said.
Micron (MU) was downgraded at Bank of America/Merrill Lynch to neutral from buy. Valuation call, based on a $20.50 price target, BofA/Merrill said.
Nucor (NUE) was downgraded at Wells Fargo to market perform from outperform. Valuation call, Wells Fargo said.
VeriFone Systems (PAY) was upgraded at Jefferies to buy from hold. Company is executing in FCF and should be positioned for some market share recovery in the first half of 2014, Jefferies said. $29 price target.Partner Re ( PRE) was upgraded at UBS to buy from neutral. Upside to 2014/15 earnings, and company is trading at a discount despite having one of the strongest balance sheets in the industry, UBS said. $114 price target.
Everest Re (RE) was downgraded at UBS to neutral from buy. No more anticipated upside, valuation call, UBS said. $161 price target.
Fresh Market (TFM) was downgraded at Sterne Agee to neutral. $44 price target. Company has struggled to grow outside its core region, Sterne Agee said.
Target (TGT) was downgraded at Bank of America/Merrill Lynch to underperform from neutral. $60 price target. Sales and margin outlooks are deteriorating, BofA/Merrill said.
US Steel (X) was downgraded at Wells Fargo to underperform from market perform. Company is already pricing in cost-cutting plans, Wells Fargo said.
Yum Brands (YUM) was upgraded at Bank of America/Merrill Lynch. $90 price target. Company can deliver solid growth in 2014 and deserves an expanded multiple, BofA/Merrill said.
Stock Comments / EPS Changes
Aruba Networks (ARUN) price target, EPS were increased at UBS. The company increased its own numbers, UBS said. Driven by lower opex and tax rates, UBS said. $19 price target and neutral rating.
Boston Scientific (BSX) numbers were raised at BMO Capital. Shares are now seen reaching $12, according to BMO Capital. Estimates were also increased, as the EP acquisition should add to earnings, BMO Capital said. Market Perform rating.Dollar Tree ( DLTR) estimates, price target were lowered at Jefferies. Dollar Tree decreased its own numbers. Weak comp in relatively easy third quarter, Jefferies said. $51 price target and hold rating.
Dollar Tree numbers were reduced at BMO Capital. Shares are now seen reaching $69. Estimates were also cut, given the company's new guidance, BMO Capital said. Outperform rating.
Marvell (MRVL) estimates, price target were increased at Benchmark through 2015. Company is leveraged to new game console launches, Benchmark said. Hold rating and new $14 price target.
Patterson Cos PDCO lowered its estimates and price target at UBS. The company lowered its own numbers. Dental segment sales growth fell short of management expectations, UBS said. $45 price target and neutral rating.
Splunk (SPLK) price target, EPS were boosted at Jefferies. Outperformance on license billings with balanced commercial growth, solid large deal flows and a strong public sector, Jefferies said. $64 price target and hold rating.